Avadel Pharmaceuticals plc Made Headway
Avadel Pharmaceuticals plc (AVDL:NASDAQ) rocketted at $5.3, representing a gain of 25.9%. On Mon, Apr 25, 2022, AVDL:NASDAQ hit a New 2-Week Low of $4.21. The stock got featured on our News Catalysts scanner on Mon, Apr 25, 2022 at 01:11 PM in the 'BIOTECH' category. From Mon, Apr 11, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days
About Avadel Pharmaceuticals plc (AVDL:NASDAQ)
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company developing and commercializing pharmaceutical products. The company's products include Bloxiverz, Vazculep, Akovaz, Karbinal ER, AcipHex Sprinkle, Cefaclor and Flexichamber.
Top 10 Gainers:
- Evoke Pharma, Inc. (EVOK:NASDAQ), 118.5%
- Nutex Health Inc. (NUTX:NASDAQ), 73.76%
- Cyngn Inc. (CYN:NASDAQ), 52.07%
- Forge Global Holdings Inc. (FRGE:NYSE), 40.38%
- Jiuzi Holdings Inc. (JZXN:NASDAQ), 27.27%
- Avadel Pharmaceuticals plc (AVDL:NASDAQ), 25.89%
- Addex Therapeutics Ltd (ADXN:NASDAQ), 23.84%
- Arch Coal, Inc. (ARCH:NYSE), 20.95%
- Lizhi Inc. (LIZI:NASDAQ), 20%
- Q&K International Group Limited (QK:NASDAQ), 18.57%